- call +1-201-465-4211
- email sales@mrinsights.biz
The use of Antidotes is since the early history of medicine. Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes. Most important development are related to the role of antidotes in the management of poisoning cases that have incurred in past few years. Various studies for instances, toxicodynamic and toxicokinetic is expected to help in improving the approach taken for the development and evaluation of antidotes. In addition due to increasing global concern for the effectiveness of antidotes has resulted in the exchange of knowledge, scientific information and clinical experience between health care professionals and scientists from different parts of the world. The evolution of antidotal therapy has been characterized with the help of new antidotes such as monoclonal antibodies, also by accurate scientific approach for the effectiveness and the complications that may occur, by novel applications of existing pharmaceuticals, and by increased cooperation and collaboration at global level.
Scope of the Report:
This report focuses on the Antidote in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Some key factors such as rising awareness and studies that are conducted for development in identifying toxins in venom bites that by government and companies for better knowledge of these drugs and antidotes is likely to drive the growth of antidote market over forecast period. Identification of snakes is highly important so as to know whether it is snake- specific anti-venoms which are less hazardous as compared to polyvalent anti-venoms. However antidote market has some restraints such as low product of anti-venoms due to rising prices of anti-venoms repressed demand resulting the treatment has declined significantly or even disappeared in some areas is expected to hinder the growth of the antidote market.
The worldwide market for Antidote is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Boehringer Ingelheim Pharmaceuticals
AstraZeneca
Novartis International
Eli Lilly
Portola
Pfizer
Bristol-Myers Squibb
Bayer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chemical Antidotes
Physical Antidotes
Pharmacological Antidotes
Market Segment by Applications, can be divided into
Animal Bites
Heavy Metal Poisoning
Others
There are 15 Chapters to deeply display the global Antidote market.
Chapter 1, to describe Antidote Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antidote, with sales, revenue, and price of Antidote, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antidote, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antidote market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antidote sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antidote Introduction
1.2 Market Analysis by Type
1.2.1 Chemical Antidotes
1.2.2 Physical Antidotes
1.2.3 Pharmacological Antidotes
1.3 Market Analysis by Applications
1.3.1 Animal Bites
1.3.2 Heavy Metal Poisoning
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim Pharmaceuticals
2.1.1 Business Overview
2.1.2 Antidote Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boehringer Ingelheim Pharmaceuticals Antidote Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Antidote Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Antidote Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis International
2.3.1 Business Overview
2.3.2 Antidote Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis International Antidote Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Antidote Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Antidote Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Portola
2.5.1 Business Overview
2.5.2 Antidote Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Portola Antidote Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Antidote Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Antidote Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Antidote Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Antidote Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bayer
2.8.1 Business Overview
2.8.2 Antidote Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bayer Antidote Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antidote Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antidote Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antidote Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antidote Manufacturer Market Share in 2017
3.3.2 Top 6 Antidote Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antidote Market Analysis by Regions
4.1 Global Antidote Sales, Revenue and Market Share by Regions
4.1.1 Global Antidote Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antidote Revenue and Market Share by Regions (2013-2018)
4.2 North America Antidote Sales and Growth Rate (2013-2018)
4.3 Europe Antidote Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antidote Sales and Growth Rate (2013-2018)
4.5 South America Antidote Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antidote Sales and Growth Rate (2013-2018)
5 North America Antidote by Countries
5.1 North America Antidote Sales, Revenue and Market Share by Countries
5.1.1 North America Antidote Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antidote Revenue and Market Share by Countries (2013-2018)
5.2 United States Antidote Sales and Growth Rate (2013-2018)
5.3 Canada Antidote Sales and Growth Rate (2013-2018)
5.4 Mexico Antidote Sales and Growth Rate (2013-2018)
6 Europe Antidote by Countries
6.1 Europe Antidote Sales, Revenue and Market Share by Countries
6.1.1 Europe Antidote Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antidote Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antidote Sales and Growth Rate (2013-2018)
6.3 UK Antidote Sales and Growth Rate (2013-2018)
6.4 France Antidote Sales and Growth Rate (2013-2018)
6.5 Russia Antidote Sales and Growth Rate (2013-2018)
6.6 Italy Antidote Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antidote by Countries
7.1 Asia-Pacific Antidote Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antidote Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antidote Revenue and Market Share by Countries (2013-2018)
7.2 China Antidote Sales and Growth Rate (2013-2018)
7.3 Japan Antidote Sales and Growth Rate (2013-2018)
7.4 Korea Antidote Sales and Growth Rate (2013-2018)
7.5 India Antidote Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antidote Sales and Growth Rate (2013-2018)
8 South America Antidote by Countries
8.1 South America Antidote Sales, Revenue and Market Share by Countries
8.1.1 South America Antidote Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antidote Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antidote Sales and Growth Rate (2013-2018)
8.3 Argentina Antidote Sales and Growth Rate (2013-2018)
8.4 Colombia Antidote Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antidote by Countries
9.1 Middle East and Africa Antidote Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antidote Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antidote Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antidote Sales and Growth Rate (2013-2018)
9.3 UAE Antidote Sales and Growth Rate (2013-2018)
9.4 Egypt Antidote Sales and Growth Rate (2013-2018)
9.5 Nigeria Antidote Sales and Growth Rate (2013-2018)
9.6 South Africa Antidote Sales and Growth Rate (2013-2018)
10 Global Antidote Market Segment by Type
10.1 Global Antidote Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antidote Sales and Market Share by Type (2013-2018)
10.1.2 Global Antidote Revenue and Market Share by Type (2013-2018)
10.2 Chemical Antidotes Sales Growth and Price
10.2.1 Global Chemical Antidotes Sales Growth (2013-2018)
10.2.2 Global Chemical Antidotes Price (2013-2018)
10.3 Physical Antidotes Sales Growth and Price
10.3.1 Global Physical Antidotes Sales Growth (2013-2018)
10.3.2 Global Physical Antidotes Price (2013-2018)
10.4 Pharmacological Antidotes Sales Growth and Price
10.4.1 Global Pharmacological Antidotes Sales Growth (2013-2018)
10.4.2 Global Pharmacological Antidotes Price (2013-2018)
11 Global Antidote Market Segment by Application
11.1 Global Antidote Sales Market Share by Application (2013-2018)
11.2 Animal Bites Sales Growth (2013-2018)
11.3 Heavy Metal Poisoning Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Antidote Market Forecast (2018-2023)
12.1 Global Antidote Sales, Revenue and Growth Rate (2018-2023)
12.2 Antidote Market Forecast by Regions (2018-2023)
12.2.1 North America Antidote Market Forecast (2018-2023)
12.2.2 Europe Antidote Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antidote Market Forecast (2018-2023)
12.2.4 South America Antidote Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antidote Market Forecast (2018-2023)
12.3 Antidote Market Forecast by Type (2018-2023)
12.3.1 Global Antidote Sales Forecast by Type (2018-2023)
12.3.2 Global Antidote Market Share Forecast by Type (2018-2023)
12.4 Antidote Market Forecast by Application (2018-2023)
12.4.1 Global Antidote Sales Forecast by Application (2018-2023)
12.4.2 Global Antidote Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antidote Picture
Table Product Specifications of Antidote
Figure Global Sales Market Share of Antidote by Types in 2017
Table Antidote Types for Major M
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
